We are Sorry, This Page doesn't Exist
Menlo Therapeutics announces results from Phase 2 trial of Serlopitant
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Evelo Announces Potential Pricing for IPO
Evelo Biosciences expects to price its more than 5 million shares in a range that results in an initial public offering valued up to almost $104 million......»»
Momenta announces presentation on potential for anti-FcRn therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Forty Seven Announces Potential Pricing for IPO
Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million......»»
AFG Holdings Announces Potential Pricing for IPO
Original equipment manufacturer AFG intends to sell more than 18 million shares in an initial public offering valued up to more than $376 million......»»
Tilray Announces Potential Pricing for IPO
Medical cannabis pioneer Tilray expects to price about 9 million shares in an initial public offering valued up to more than $165 million......»»
Sonos Announces Potential Pricing for IPO
Smart speaker maker Sonos expects to price its almost 14 million shares to result in an initial public offering valued up to more than $303 million......»»
Mesa Air Announces Potential Pricing for IPO
Regional air carrier Mesa Air Group expects to price more than 10 million shares for an initial public offering valued up to more than $184 million......»»
Eventbrite Announces Potential Pricing for IPO
Eventbrite intends to price its 10 million shares to result in an initial public offering valued up to more than $241 million......»»
Bank7 Announces Potential Pricing for IPO
Bank7 intends to price more than 3 million shares to result in an initial public offering valued up to more than $80 million......»»
SurveyMonkey Announces Potential Pricing for IPO
SurveyMonkey expects to price more than 13 million shares for an initial public offering valued up to more than $170 million......»»
Upwork Announces Potential Pricing for IPO
Upwork expects to price more than 12 million shares to effect an initial public offering valued up to more than $169 million......»»
Kodiak Sciences Announces Potential Pricing for IPO
Clinical-stage biopharmaceutical company Kodiak Sciences expects to price 9 million shares for an initial public company valued up to more than $155 million......»»
SI-Bone Announces Potential Pricing for IPO
Medical device company SI-Bone intends to list 6 million shares in an initial public offering valued up to more than $103 million......»»
SolarWinds Announces Potential Pricing for IPO
Solar Winds intends to list 42 million shares in an initial public offering valued up to more than $917 million......»»
Anaplan Announces Potential Pricing for IPO
Connected planning pioneer Anaplan expects to price 15 million shares for an initial public offering valued up to about $303 million......»»
Yeti Announces Potential Pricing for IPO
Outdoor and recreation products maker Yeti intends to price 20 million shares for an initial public offering valued up to about $483 million......»»
Twist Bio Announces Potential Pricing for IPO
Synthetic biology company Twist Bioscience expects to price 5 million shares for an initial public offering valued up to more than $103 million......»»
Axonics Announces Potential Pricing for IPO
Medical technology company Axonics Modulation Technologies is offering more than 6 million shares in an initial public offering valued up to more than $122 million......»»
Orchard RX Announces Potential Pricing for IPO
Biopharmaceutical company Orchard RX is offering more than 13 million shares in an initial public offering valued up to more than $245 million......»»